Assessing Off-Target Editing of CRISPR-Cas9 Systems.
作者信息
Pruett-Miller Shondra M
机构信息
Department of Cell and Molecular Biology, Center for Advanced Genome Engineering, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
出版信息
CRISPR J. 2020 Dec;3(6):430-432. doi: 10.1089/crispr.2020.29116.smi.
Abstract
摘要
相似文献
1
Assessing Off-Target Editing of CRISPR-Cas9 Systems.评估CRISPR-Cas9系统的脱靶编辑
CRISPR J. 2020 Dec;3(6):430-432. doi: 10.1089/crispr.2020.29116.smi.
2
CRISPR-Cas9 for cancer therapy: Opportunities and challenges.CRISPR-Cas9 用于癌症治疗：机遇与挑战。
Cancer Lett. 2019 Apr 10;447:48-55. doi: 10.1016/j.canlet.2019.01.017. Epub 2019 Jan 23.
3
A Toolkit of CRISPR-Based Genome Editing Systems in Drosophila.果蝇中基于CRISPR的基因组编辑系统工具包
J Genet Genomics. 2015 Apr 20;42(4):141-9. doi: 10.1016/j.jgg.2015.02.007. Epub 2015 Mar 12.
4
Use of CRISPR/Cas Genome Editing Technology for Targeted Mutagenesis in Rice.利用CRISPR/Cas基因组编辑技术在水稻中进行靶向诱变
Methods Mol Biol. 2017;1498:33-40. doi: 10.1007/978-1-4939-6472-7_3.
5
Multiplex gene editing in rice with simplified CRISPR-Cpf1 and CRISPR-Cas9 systems.利用简化的 CRISPR-Cpf1 和 CRISPR-Cas9 系统在水稻中进行多重基因编辑。
J Integr Plant Biol. 2018 Aug;60(8):626-631. doi: 10.1111/jipb.12667. Epub 2018 Jul 7.
6
Epigenome editing by CRISPR/Cas9 in clinical settings: possibilities and challenges.CRISPR/Cas9 在临床环境中的表观基因组编辑：可能性与挑战。
Brief Funct Genomics. 2020 May 20;19(3):215-228. doi: 10.1093/bfgp/elz035.
7
CRISPR-Cas9 System: Opportunities and Concerns.CRISPR-Cas9系统：机遇与担忧。
Clin Chem. 2016 Oct;62(10):1304-11. doi: 10.1373/clinchem.2016.263186. Epub 2016 Aug 22.
8
Cutting Edge Genetics: CRISPR/Cas9 Editing of Plant Genomes.前沿遗传学：植物基因组的 CRISPR/Cas9 编辑。
Plant Cell Physiol. 2018 Aug 1;59(8):1608-1620. doi: 10.1093/pcp/pcy079.
9
CRISPR-Cas9: A revolution in genome editing in rheumatic diseases.CRISPR-Cas9：风湿性疾病基因组编辑领域的一场革命。
Joint Bone Spine. 2017 Jan;84(1):1-4. doi: 10.1016/j.jbspin.2016.09.012. Epub 2016 Nov 4.
10
Cas9 immunity creates challenges for CRISPR gene editing therapies.Cas9 免疫为 CRISPR 基因编辑疗法带来挑战。
Nat Commun. 2018 Aug 29;9(1):3497. doi: 10.1038/s41467-018-05843-9.
引用本文的文献
1
Delivery of gene editing therapeutics.基因编辑治疗药物的递送。
Nanomedicine. 2023 Nov;54:102711. doi: 10.1016/j.nano.2023.102711. Epub 2023 Oct 7.
2
Engineered CRISPR/Cas13d Sensing hTERT Selectively Inhibits the Progression of Bladder Cancer .工程化的CRISPR/Cas13d检测人端粒酶逆转录酶可选择性抑制膀胱癌进展
Front Mol Biosci. 2021 Mar 19;8:646412. doi: 10.3389/fmolb.2021.646412. eCollection 2021.
Zotero 插件